{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:54:35Z","timestamp":1760853275931},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2000,4]]},"DOI":"10.1007\/s11894-000-0092-y","type":"journal-article","created":{"date-parts":[[2007,5,19]],"date-time":"2007-05-19T19:56:26Z","timestamp":1179604586000},"page":"99-103","source":"Crossref","is-referenced-by-count":7,"title":["Current therapies and clinical controversies in the management of primary sclerosing cholangitis"],"prefix":"10.1007","volume":"2","author":[{"given":"Richard T.","family":"Prall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith D.","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell H.","family":"Wiesner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas F.","family":"LaRusso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"92_CR1","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2214\/ajr.171.4.9762990","volume":"171","author":"O Ernst","year":"1998","unstructured":"Ernst O, Asselah T, Sergent G, et al.: MR cholangiography in primary sclerosing cholangitis. Am J Roentgenol 1998, 171:1027\u20131030.","journal-title":"Am J Roentgenol"},{"key":"92_CR2","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/hep.510280316","volume":"28","author":"S Keiding","year":"1998","unstructured":"Keiding S, Hansen SB, Rasmussen HH, et al.: Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography [see comments]. Hepatology 1998, 28:700\u2013706. This report describes the successful use of positron emission tomography scanning to detect cholangiocarcinomas in patients with PSC. The advantage to this technique seems to be a greater sensitivity for finding small tumors, some as small as one centimeter, when presumably intervention would be the most effective. Prospective studies should be done to confirm this.","journal-title":"Hepatology"},{"key":"92_CR3","first-page":"A1266","volume":"30","author":"W Kim","year":"1999","unstructured":"Kim W, Lindor K, Broome U, et al.: Independent validation of the Mayo natural history model for primary sclerosing cholangitis [abstract]. Hepatology 1999, 30:A1266.","journal-title":"Hepatology"},{"key":"92_CR4","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/hep.510250501","volume":"25","author":"K Shetty","year":"1997","unstructured":"Shetty K, Rybicki L, Carey WD: The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology 1997, 25:1049\u20131053.","journal-title":"Hepatology"},{"key":"92_CR5","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/hep.510290607","volume":"29","author":"WR Kim","year":"1999","unstructured":"Kim WR, Poterucha JJ, Wiesner RH, et al.: The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. Hepatology 1999, 29:1643\u20131648. This paper reviews the most accurate prognostic method to date which remains clinically useful.","journal-title":"Hepatology"},{"key":"92_CR6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","volume":"336","author":"KD Lindor","year":"1997","unstructured":"Lindor KD: Ursodiol for primary sclerosing cholangitis: Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group [see comments]. N Engl J Med 1997, 336:691\u2013695. Report of a randomized, double-blinded study of 105 patients with PSC comparing ursodeoxycholic acid with placebo. This well-conducted study found no benefit when examining time to treatment failure, and subanalysis of patients with early disease also showed no benefit.","journal-title":"N Engl J Med"},{"key":"92_CR7","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1023\/A:1026673811278","volume":"44","author":"P Angulo","year":"1999","unstructured":"Angulo P, Bharucha AE, Jorgensen RA, et al.: Oral nicotine in treatment of primary sclerosing cholangitis: a pilot study. Dig Dis Sci 1999, 44:602\u2013607.","journal-title":"Dig Dis Sci"},{"key":"92_CR8","first-page":"A1265","volume":"30","author":"P Angulo","year":"1999","unstructured":"Angulo P, Batts K, Jorgensen R, et al.: Budesonide in the treatment of primary sclerosing cholangitis: a preliminary study [abstract]. Hepatology 1999, 30:A1265.","journal-title":"Hepatology"},{"key":"92_CR9","first-page":"A757","volume":"112","author":"S Mitchell","year":"1997","unstructured":"Mitchell S, Bansi D, Hunt N, et al.: High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): results after two years of a randomized,double-blind, placebo-controlled trial [Abstract]. Gastroenterology 1997, 112:A757.","journal-title":"Gastroenterology"},{"key":"92_CR10","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0168-8278(97)80421-7","volume":"26","author":"A Stiehl","year":"1997","unstructured":"Stiehl A, Rudolph G, Sauer P, et al.: Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis: an 8-year prospective study. J Hepatol 1997, 26:560\u2013566.","journal-title":"J Hepatol"},{"key":"92_CR11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0016-5107(97)70123-8","volume":"46","author":"Milligen de Wit AW van","year":"1997","unstructured":"van Milligen de Wit AW, Rauws EA, van Bracht J, et al.: Lack of complications following short-term stent therapy for extrahepatic bile duct strictures in primary sclerosing cholangitis. Gastrointest Endosc 1997, 46:344\u2013347.","journal-title":"Gastrointest Endosc"},{"key":"92_CR12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00000658-199803000-00014","volume":"227","author":"SA Ahrendt","year":"1998","unstructured":"Ahrendt SA, Pitt HA, Kalloo AN, et al.: Primary sclerosing cholangitis: resect, dilate, or transplant? Ann Surg 1998, 227:412\u2013423. This review of 146 patients with PSC managed over a 14-year period suggests a survival benefit for non-transplant biliary reconstructive surgery in patients who do not have cirrhosis.","journal-title":"Ann Surg"},{"key":"92_CR13","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archsurg.1994.01420340071012","volume":"129","author":"JA Myburgh","year":"1994","unstructured":"Myburgh JA: Surgical biliary drainage in primary sclerosing cholangitis: the role of the Hepp-Couinaud approach. Arch Surg 1994, 129):1057\u20131062.","journal-title":"Arch Surg"},{"key":"92_CR14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0039-6060(05)80078-9","volume":"117","author":"O Farges","year":"1995","unstructured":"Farges O, Malassagne B, Sebagh M, Bismuth H: Primary sclerosing cholangitis: liver transplantation or biliary surgery. Surgery 1995, 117:146\u2013155.","journal-title":"Surgery"},{"key":"92_CR15","first-page":"335","volume":"177","author":"KM Abu-Elmagd","year":"1993","unstructured":"Abu-Elmagd KM, Malinchoc M, Dickson ER, et al.: Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet 1993, 177:335\u2013344.","journal-title":"Surg Gynecol Obstet"},{"key":"92_CR16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/hep.1840220213","volume":"22","author":"S Narumi","year":"1995","unstructured":"Narumi S, Roberts JP, Emond JC, et al.: Liver transplantation for sclerosing cholangitis. Hepatology 1995, 22:451\u2013457.","journal-title":"Hepatology"},{"key":"92_CR17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2214\/ajr.161.2.8333366","volume":"161","author":"R Sheng","year":"1993","unstructured":"Sheng R, Zajko AB, Campbell WL, Abu-Elmagd K: Biliary strictures in hepatic transplants: prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases. Am J Roentgenol 1993, 161:297\u2013300.","journal-title":"Am J Roentgenol"},{"key":"92_CR18","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2214\/ajr.166.5.8615253","volume":"166","author":"R Sheng","year":"1996","unstructured":"Sheng R, Campbell WL, Zajko AB, Baron RL: Cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: evidence of recurrent disease. Am J Roentgenol 1996, 166:1109\u20131113.","journal-title":"Am J Roentgenol"},{"key":"92_CR19","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510290427","volume":"29","author":"IW Graziadei","year":"1999","unstructured":"Graziadei IW, Wiesner RH, Batts KP, et al.: Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology 1999, 29:1050\u20131056. This paper describes the clinical and radiographic criteria used to discern recurrent PSC after transplantation.","journal-title":"Hepatology"},{"key":"92_CR20","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","volume":"30","author":"IW Graziadei","year":"1999","unstructured":"Graziadei IW, Wiesner RH, Marotta PJ, et al.: Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 1999, 30:1121\u20131127. This report describes a single center\u2019s experience with transplantation for PSC. Results of transplantation in 150 patients over a median of 55 months were surveyed and identified factors which negatively impacted outcome, although overall patient and graft survival were excellent.","journal-title":"Hepatology"},{"key":"92_CR21","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00000658-199705000-00004","volume":"225","author":"JA Goss","year":"1997","unstructured":"Goss JA, Shackleton CR, Farmer DG, et al.: Orthotopic liver transplantation for primary sclerosing cholangitis: a 12-year single center experience [includes discussion]. Ann Surg 1997, 225:472\u2013483.","journal-title":"Ann Surg"},{"issue":"suppl 4","key":"92_CR22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1023\/A:1008301522956","volume":"bd10","author":"LL Gunderson","year":"1999","unstructured":"Gunderson LL, Haddock MG, Burch P, et al.: Future role of radiotherapy as a component of treatment in biliopancreatic cancers. Ann Oncol 1999, 10(suppl 4):291\u2013295. This excellent review describes the current approach to patients with unresectable cholangiocarcinoma and provides data from recent studies of combination chemotherapy and radiation. The authors describe new modalities and future direction of therapy.","journal-title":"Ann Oncol"},{"key":"92_CR23","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1053\/gast.1996.v110.pm8613056","volume":"110","author":"Erpecum KJ van","year":"1996","unstructured":"van Erpecum KJ, Smits SJ, van de Meeberg PC, et al.: Risk of primary sclerosing cholangitis is associated with nonsmoking behavior [see comments]. Gastroenterology 1996, 110:1503\u20131506.","journal-title":"Gastroenterology"},{"key":"92_CR24","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1053\/gast.1996.v110.pm8613055","volume":"110","author":"EV Loftus Jr","year":"1996","unstructured":"Loftus EV Jr, Sandborn WJ, Tremaine WJ, et al.: Primary sclerosing cholangitis is associated with nonsmoking: a case-control study [see comments]. Gastroenterology 1996, 110:1496\u20131502.","journal-title":"Gastroenterology"},{"key":"92_CR25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.510270201","volume":"27","author":"A Bergquist","year":"1998","unstructured":"Bergquist A, Glaumann H, Persson B, Broome U: Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 1998, 27:311\u2013316.","journal-title":"Hepatology"},{"key":"92_CR26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep.510310103","volume":"31","author":"N Chalasani","year":"2000","unstructured":"Chalasani N, Baluyut A, Ismail A, Zaman A: Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology 2000, 31:7\u201311. In this large study, alcohol consumption was found to be the only risk factor for development of cholangiocarcinoma in patients with PSC.","journal-title":"Hepatology"},{"key":"92_CR27","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/0016-5085(92)90308-L","volume":"102","author":"U Broome","year":"1992","unstructured":"Broome U, Lindberg G, Lofberg R: Primary sclerosing cholangitis in ulcerative colitis: a risk factor for the development of dysplasia and DNA aneuploidy? [see comments]. Gastroenterology 1992, 102:1877\u20131880.","journal-title":"Gastroenterology"},{"key":"92_CR28","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/gut.41.4.522","volume":"41","author":"D Kornfeld","year":"1997","unstructured":"Kornfeld D, Ekbom A, Ihre T: Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study [see comments]. Gut 1997, 41:522\u2013525.","journal-title":"Gut"},{"key":"92_CR29","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/(SICI)1097-0142(19980301)82:5<822::AID-CNCR4>3.0.CO;2-L","volume":"82","author":"KW Nuako","year":"1998","unstructured":"Nuako KW, Ahlquist DA, Sandborn WJ, et al.: Primary sclerosing cholangitis and colorectal carcinoma in patients with chronic ulcerative colitis: a case-control study. Cancer 1998, 82:822\u2013826.","journal-title":"Cancer"},{"key":"92_CR30","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/BF02049156","volume":"38","author":"U Broome","year":"1995","unstructured":"Broome U, Lofberg R, Lundqvist K, Veress B: Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis. Dis Colon Rectum 1995, 38:1301\u20131305.","journal-title":"Dis Colon Rectum"},{"key":"92_CR31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.510270308","volume":"27","author":"EV Loftus Jr","year":"1998","unstructured":"Loftus EV Jr, Aguilar HI, Sandborn WJ, et al.: Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology 1998, 27:685\u2013690.","journal-title":"Hepatology"},{"key":"92_CR32","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0025-6196(12)60696-X","volume":"68","author":"JC Nichols","year":"1993","unstructured":"Nichols JC, Gores GJ, LaRusso NF, et al.: Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc 1993, 68:874\u2013879.","journal-title":"Mayo Clin Proc"},{"key":"92_CR33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/hep.510310137","volume":"3","author":"Groen P de","year":"2000","unstructured":"de Groen P: Cholangiocarcinoma in primary sclerosing cholangitis: who is at risk and how do we screen? Hepatology 2000, 3:247\u2013248. This excellent article provides commentary on putative risk factors for cholangiocarcinoma development in PSC and offers a logical algorithm for screening these patients.","journal-title":"Hepatology"},{"key":"92_CR34","first-page":"446A","volume":"28","author":"K Fleming","year":"1998","unstructured":"Fleming K, Clausen O, Glaumann H, et al.: Biliary dysplasia in primary sclerosing cholangitis as a marker of increased risk of cholangiocarcinoma [abstract]. Hepatology 1998, 28:446A.","journal-title":"Hepatology"},{"key":"92_CR35","first-page":"A1262","volume":"30","author":"S Kubicka","year":"1999","unstructured":"Kubicka S, Meier P, Fleming P, et al.: K-ras mutations in the bile fluids of patients with primary sclerosing cholangitis as an prognostic factor for cholangiocarcinogenesis [Abstract]. Hepatology 1999, 30:A1262.","journal-title":"Hepatology"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-000-0092-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-000-0092-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-000-0092-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:03:38Z","timestamp":1559419418000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-000-0092-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["92"],"URL":"https:\/\/doi.org\/10.1007\/s11894-000-0092-y","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}